All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload

Journey of Voyager's ALS gene therapy to clinic hindere...

Feb 12, 2025  0

Sutro discards CEO, 50% of staff, sole clinical-stage ADC and manufacturing site to save cash

Sutro discards CEO, 50% of staff, sole clinical-stage A...

Mar 14, 2025  0

Fierce Biotech Fundraising Tracker '25: Callio launches with $187M series A; Eikon's eye-catching $350M series D

Fierce Biotech Fundraising Tracker '25: Callio launches...

Mar 3, 2025  0